Directorio de personas
Francisco Torres Bondia

Francisco Torres Bondia

Grado: Licenciado/a


ftorres(ELIMINAR)@gss.cat

Grupos

Publicaciones

  • Torres-Bondia F; de Batlle J; Galván L; Buti M; Barbé F; Piñol-Ripoll G

    Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015.

    BMC PUBLIC HEALTH 22 818-818. .

    [doi:10.1186/s12889-022-13217-6]

  • Torres-Bondia F; Dakterzada F; Galván L; Buti M; Besanson G; Grill E; Buil R; de Batlle J; Piñol-Ripoll G

    Benzodiazepine and Z-drug use and the risk of developing dementia.

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 25 261-268. .

    [doi:10.1093/ijnp/pyab073]

  • Jatem, E; Lima, J; Montoro, B; Torres-Bondia, F; Segarra, A

    Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome

    Kidney International Reports 6 101-109. .

    [doi:10.1016/j.ekir.2020.09.046]

  • Torres-Bondia F; Dakterzada F; Galván L; Buti M; Besanson G; Gill E; Buil R; de Batlle J; Piñol-Ripoll G

    Proton pump inhibitors and the risk of Alzheimer's disease and non-Alzheimer's dementias.

    SCIENTIFIC REPORTS 10 21046-21046. .

    [doi:10.1038/s41598-020-78199-0]

  • Torres-Bondia, F; de Batlle, J; Galvan, L; Buti, M; Barbe, F; Piñol-Ripoll G

    Trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs in the health region of Lleida from 2002 to 2015.

    BMC PUBLIC HEALTH 20 818-818. .

    [doi:10.1186/s12889-020-08984-z]